Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Lich

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with NecroptosisPhilip A Harris, Deepak Bandyopadhyay, Scott B Berger, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic CancerPhilip A Harris, Jill M Marinis, John D Lich, et al.
Molecular Cell|December 3, 2014
RIP3 induces apoptosis independent of pronecrotic kinase activityPratyusha Mandal, Scott B Berger, Sirika Pillay, et al.
Cancer Cell|October 13, 2020
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic CancerWei Wang, Jill M Marinis, Allison M Beal, et al.
Cancer Cell|November 14, 2018
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic CancerWei Wang, Jill M Marinis, Allison M Beal, et al.
Journal of Medicinal Chemistry|February 3, 2017
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory DiseasesPhilip A Harris, Scott B Berger, Jae U Jeong, et al.
Journal of Medicinal Chemistry|April 24, 2019
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) KinasePhilip A Harris, Nicolas Faucher, Nicolas George, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with NecroptosisPhilip A Harris, Deepak Bandyopadhyay, Scott B Berger, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic CancerPhilip A Harris, Jill M Marinis, John D Lich, et al.
Molecular Cell|December 3, 2014
RIP3 induces apoptosis independent of pronecrotic kinase activityPratyusha Mandal, Scott B Berger, Sirika Pillay, et al.
Cancer Cell|October 13, 2020
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic CancerWei Wang, Jill M Marinis, Allison M Beal, et al.
Cancer Cell|November 14, 2018
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic CancerWei Wang, Jill M Marinis, Allison M Beal, et al.
Journal of Medicinal Chemistry|February 3, 2017
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory DiseasesPhilip A Harris, Scott B Berger, Jae U Jeong, et al.
Journal of Medicinal Chemistry|April 24, 2019
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) KinasePhilip A Harris, Nicolas Faucher, Nicolas George, et al.
Pageof 3